Bioventix (BVXP)

 

BVXP Share PerformanceMore

52 week high2,045.0 15/05/17
52 week low899.5 25/07/16
52 week change 937.5 (90.80%)
4 week volume111,918 27/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Bioventix to get royalties from Siemens troponin test

Bioventix has described the launch of a new test by Siemens for troponin, a key biomarker used in heart attack diagnostic...

Holding(s) in Company

For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BIOVENTIX PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal o...

Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Bioventix (Sedol B4QVDF0 ) 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instrum...

Issue of Equity

Bioventix plc (?Bioventix? or ?the Company?) Issue of Equity Bioventix plc (BVXP) a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that it has applied for 40,018 ordinary shares of 5 pence each (the ?Option Shares?) to be admitted to trading on AIM (?Adm...

Broker Forecast - finnCap issues a broker note on Bioventix Plc

finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 1750p ...

Bioventix pre-tax profits rise

Bioventix's pre-tax profits rose by 49% to 2.48m in the six months to the end of December. Turnover rose by 32% to 3.12m a...

Interim Results

Bioventix plc UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2016 Bioventix plc (BVXP) (?Bioventix? or ?the Company?), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces its unaudited interim financial results for t...

10 fast-paced growth stocks for all traders

Now is a great time to be a stock trader, argues Mark Minervini, a former US Investing Champion. Stockopedia's Ben Hobs...

Fundamental DataMore

P/E ratio28.476
EPS69.18
Dividend yield2.157 %

Latest discussion posts More

  • Re: Add BVXP to my future tech portfolio

    Daz, Welcome on board. "This is a business built on real products " Much much better than that. Louis B Meyer (who built MGM into the largest film studio in the world ...
    15-May-2017
    Hardboy
  • Add BVXP to my future tech portfolio

    Just invested. Been awaiting a dip to buy into but despite that thought have bought in today as no dip in sight! I like the product, cash pile, profits and dividend. ...
    15-May-2017
    dazurtrader
  • Re: Interims

    Just to add to my post, Bioventix's figures in recent years have not been skewed by exceptional items. If one looks at the fundamentals page & the bar charts for sales, profit, ...
    27-Mar-2017
    Hardboy

Users' HoldingsMore

Users who hold Bioventix also hold..
LLOYDS GRP.27%
SOMERO ENTER DI22%
GLAXOSMITHKLINE21%
ZYTRONIC20%
OPTIBIOTIX H.18%

Codes & Symbols

ISINGB00B4QVDF07
SymbolsBVXP, LSE:BVXP, BVXP.L, BVXP:LN, LON:BVXP, XLON:BVXP